Orexin receptor biology
Search documents
Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
CNBC· 2026-03-31 14:46
Lilly Chair and CEO Dave Ricks speaks during a press conference for Eli Lilly and Company in Houston, Texas, U.S., Sept. 23, 2025.Eli Lilly has agreed to pay up to $7.8 billion to acquire Centessa Pharmaceuticals and its experimental drug for excessive daytime sleepiness, the company said Tuesday.Centessa is one of several companies working on a new class of drugs to treat narcolepsy, a condition that makes it difficult for people to stay awake during the day. The drugs may also be used to treat other neuro ...
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
Prnewswire· 2026-03-31 10:45
<!doctype html> <!-- For structured data --> <!-- For language declaration --> Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders <!-- Additional Authorable Meta tags --> Accessibility StatementSkip Navigation<!-- -->Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)Centessa Logo<!-- static-gallery --> <!-- no asserts::-->Centessa's OX2R agonist pipeline includes a potential best-in-class therapeutic with significant promise to meaningfully improve outcomes ...
